R01 CA166770/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2013	4
2014	2
2015	2
2016	2
2017	2
2018	1
2019	1
2022	2
2024	0

1

Dendritic cells can prime anti-tumor CD8⁺ T cell responses through major histocompatibility complex cross-dressing.

MacNabb BW, Tumuluru S, Chen X, Godfrey J, Kasal DN, Yu J, Jongsma MLM, Spaapen RM, Kline DE, Kline J. MacNabb BW, et al. Immunity. 2022 Jun 14;55(6):982-997.e8. doi: 10.1016/j.immuni.2022.04.016. Epub 2022 May 25. Immunity. 2022. PMID: 35617964 Free PMC article.

2

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.

Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, Xu H, Peng H, Fu YX, Xu MM. Liu X, et al. Nat Med. 2015 Oct;21(10):1209-15. doi: 10.1038/nm.3931. Epub 2015 Aug 31. Nat Med. 2015. PMID: 26322579 Free PMC article.

3

Mechanisms of Immune Tolerance in Leukemia and Lymphoma.

Curran EK, Godfrey J, Kline J. Curran EK, et al. Trends Immunol. 2017 Jul;38(7):513-525. doi: 10.1016/j.it.2017.04.004. Epub 2017 May 13. Trends Immunol. 2017. PMID: 28511816 Free PMC article. Review.

4

Targeting the innate immune system as immunotherapy for acute myeloid leukemia.

Curran E, Corrales L, Kline J. Curran E, et al. Front Oncol. 2015 Apr 9;5:83. doi: 10.3389/fonc.2015.00083. eCollection 2015. Front Oncol. 2015. PMID: 25914882 Free PMC article. Review.

5

PD-1 regulates extrathymic regulatory T-cell differentiation.

Chen X, Fosco D, Kline DE, Meng L, Nishi S, Savage PA, Kline J. Chen X, et al. Eur J Immunol. 2014 Sep;44(9):2603-16. doi: 10.1002/eji.201344423. Epub 2014 Aug 18. Eur J Immunol. 2014. PMID: 24975127 Free PMC article.

6

Dendritic cells can prime anti-tumor CD8⁺ T cell responses through major histocompatibility complex cross-dressing.

MacNabb BW, Chen X, Tumuluru S, Godfrey J, Kasal DN, Yu J, Jongsma MLM, Spaapen RM, Kline DE, Kline J. MacNabb BW, et al. Immunity. 2022 Nov 8;55(11):2206-2208. doi: 10.1016/j.immuni.2022.09.015. Immunity. 2022. PMID: 36351377 Free PMC article. No abstract available.

7

Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.

Hossain DM, Dos Santos C, Zhang Q, Kozlowska A, Liu H, Gao C, Moreira D, Swiderski P, Jozwiak A, Kline J, Forman S, Bhatia R, Kuo YH, Kortylewski M. Hossain DM, et al. Blood. 2014 Jan 2;123(1):15-25. doi: 10.1182/blood-2013-07-517987. Epub 2013 Oct 29. Blood. 2014. PMID: 24169824 Free PMC article.

8

STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia.

Curran E, Chen X, Corrales L, Kline DE, Dubensky TW Jr, Duttagupta P, Kortylewski M, Kline J. Curran E, et al. Cell Rep. 2016 Jun 14;15(11):2357-66. doi: 10.1016/j.celrep.2016.05.023. Epub 2016 Jun 2. Cell Rep. 2016. PMID: 27264175 Free PMC article.

9

CD8α⁺ Dendritic Cells Dictate Leukemia-Specific CD8⁺ T Cell Fates.

Kline DE, MacNabb BW, Chen X, Chan WC, Fosco D, Kline J. Kline DE, et al. J Immunol. 2018 Dec 15;201(12):3759-3769. doi: 10.4049/jimmunol.1801184. Epub 2018 Nov 12. J Immunol. 2018. PMID: 30420437 Free PMC article.

10

Negligible Role for Deletion Mediated by cDC1 in CD8⁺ T Cell Tolerance.

MacNabb BW, Kline DE, Albright AR, Chen X, Leventhal DS, Savage PA, Kline J. MacNabb BW, et al. J Immunol. 2019 May 1;202(9):2628-2635. doi: 10.4049/jimmunol.1801621. Epub 2019 Mar 22. J Immunol. 2019. PMID: 30902900 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year